Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 11, 2014Science Translational MedicineOpen Access

RNAi Therapies: Drugging the Undruggable

View Full Paper
Ask AI
Bookmark
Share

Authors

SWSherry Y. WuQueensland University of TechnologyGLGabriel López-BeresteinUniversity of PisaGCGeorge A. CălinKagoshima University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Wu et al. (2014) studied this question.

synapsesocial.com/papers/6a096e4300217ed3fb33f560https://doi.org/10.1126/scitranslmed.3008362
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Exploiting Endocytosis for Nanomedicines2013 · 211 citations
  2. 2Co-Injection of a Targeted, Reversibly Masked Endosomolytic Polymer Dramatically Improves the Efficacy of Cholesterol-Conjugated Small Interfering RNAs <i>In Vivo</i>2012 · 100 citations
  3. 3Lipid-like materials for low-dose, in vivo gene silencing2010 · 980 citations
  4. 4First-in-Humans Trial of an RNA Interference Therapeutic Targeting VEGF and KSP in Cancer Patients with Liver Involvement2013 · 710 citations
  5. 5Synthetic lethality between <i>CCNE1</i> amplification and loss of <i>BRCA1</i>2013 · 230 citations